Perspective Therapeutics, a diversified medical technology and radiopharmaceutical company, agreed to acquire the Somerset facility, a radiopharmaceutical manufacturing facility, from Lantheus, a radiopharmaceutical-focused company. Financial terms were not disclosed. “Perspective stands at the forefront of innovation in precision oncology, particularly in the development of alpha therapies and complementary diagnostic imaging agents. In addition, Perspective’s acquisition of the Somerset radiopharmaceutical manufacturing facility will provide the company with an in-house manufacturing footprint to support its lead portfolio,” Thijs Spoor, Perspective Therapeutics CEO.